UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018)

Journal of global antimicrobial resistance., 2022-12, Vol.31, p.82-89

2022

Volltextzugriff (PDF)

Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program

Antimicrobial agents and chemotherapy, 2021-03, Vol.65 (4)

2021

Volltextzugriff (PDF)

Study of an antifungal medicine isavuconazole used in treatment of mold infections in China: A plain language summary

Future microbiology, 2023-01, Vol.18 (2), p.87-91

2023

Volltextzugriff (PDF)

Antifungal drugs work together to treat germs causing fungal infections

Future microbiology, 2021-07, Vol.16 (11), p.765-768

2021

Volltextzugriff (PDF)

In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China

Infection and drug resistance, 2022-04, Vol.15, p.2101-2113

2022

Volltextzugriff (PDF)

A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States

Human vaccines & immunotherapeutics, 2016-01, Vol.12 (1), p.206-212

2016

Volltextzugriff (PDF)

The identification of bacterial gene expression differences using mRNA-based isothermal subtractive hybridization

Canadian journal of microbiology, 1995-02, Vol.41 (2), p.152-156

1995

Volltextzugriff (PDF)

mRNA Subtractive Hybridization for the Isolation and Identification of Tissue Culture-Induced Determinants from Haemophilus influenzae Biogroup Aegyptius, the Causative Agent of Brazilian Purpuric Fever

Annals of the New York Academy of Sciences, 1994-09, Vol.730 (1), p.269-272

1994

Volltextzugriff (PDF)

Human microvascular endothelial cell toxicity caused by Brazilian purpuric fever-associated strains of Haemophilus influenzae biogroup aegyptius

The Journal of infectious diseases, 1994-02, Vol.169 (2), p.430

1994

Volltextzugriff (PDF)

Human Microvascular Endothelial Cell Toxicity Caused by Brazilian PurpuricFever-Associated Strains of Haemophilus influenzae Biogroup Aegyptius

The Journal of infectious diseases, 1994-02, Vol.169 (2), p.430-433

1994

Volltextzugriff (PDF)

A Tissue Culture Model for Studying the Pathogenesis of Brazilian Purpuric Fever

Annals of the New York Academy of Sciences, 1994-09, Vol.730 (1), p.260-262

1994

Volltextzugriff (PDF)

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019

Antimicrobial agents and chemotherapy, 2023-05, Vol.67 (5), p.e0140622-e0140622

2023

Volltextzugriff (PDF)

In vitro activity of ceftazidime-avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020

Microbiology spectrum, 2024-03, Vol.12 (3), p.e0147323-e0147323

2024

Volltextzugriff (PDF)

Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017–2020

Journal of global antimicrobial resistance., 2023-09, Vol.34, p.113-118

2023

Volltextzugriff (PDF)

Erratum for Estabrook et al., "Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019"

Antimicrobial agents and chemotherapy, 2024-03, Vol.68 (3), p.e0164023-e0164023

2024

Volltextzugriff (PDF)

Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019

Journal of global antimicrobial resistance., 2023-06, Vol.33, p.360-367

2023

Volltextzugriff (PDF)

In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020

Antibiotics (Basel), 2023-07, Vol.12 (8), p.1237

2023

Volltextzugriff (PDF)

Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019

Journal of antimicrobial chemotherapy, 2023-07, Vol.78 (7), p.1606-1615

2023

Volltextzugriff (PDF)

Design of a Brushless Doubly-Fed Machine for Aviation Electric Propulsion

IEEE transactions on industry applications, 2022-09, Vol.58 (5), p.6057-6068

2022

Volltextzugriff (PDF)

In vitro Activity of Ceftaroline Against Isolates of Gram-Positive Bacteria from Patients with Bloodstream Infections Collected as a Part of ATLAS Between 2017 and 2020

Infection and drug resistance, 2024-01, Vol.17, p.343-354

2024

Volltextzugriff (PDF)

Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019

Journal of global antimicrobial resistance., 2022-12, Vol.31, p.239-247

2022

Volltextzugriff (PDF)

The global response to the threat of antimicrobial resistance and the important role of vaccines

Pharmaceuticals policy and law, 2016-11, Vol.18 (1-4), p.179-197

2016

Volltextzugriff (PDF)

Antimicrobial Activity of Ceftazidime–Avibactam and Comparators Against Fluoroquinolone-Resistant Klebsiella pneumoniae Collected Globally from Antimicrobial Testing Leadership and Surveillance: 2018–2019

Microbial drug resistance (Larchmont, N.Y.), 2022-11, Vol.28 (11), p.1019-1027

2022

Volltextzugriff (PDF)

Vaccines: A review of immune-based interventions to prevent and treat disease

Journal of clinical pharmacology, 2015-03, Vol.55 (S3), p.S93-S102

2015

Volltextzugriff (PDF)

Cancer risk in living kidney donors

American journal of transplantation, 2022-08, Vol.22 (8), p.2006-2015

2022

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(18)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018)

Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program

Study of an antifungal medicine isavuconazole used in treatment of mold infections in China: A plain language summary

Antifungal drugs work together to treat germs causing fungal infections

In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China

A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States

The identification of bacterial gene expression differences using mRNA-based isothermal subtractive hybridization

mRNA Subtractive Hybridization for the Isolation and Identification of Tissue Culture-Induced Determinants from Haemophilus influenzae Biogroup Aegyptius, the Causative Agent of Brazilian Purpuric Fever

Human microvascular endothelial cell toxicity caused by Brazilian purpuric fever-associated strains of Haemophilus influenzae biogroup aegyptius

Human Microvascular Endothelial Cell Toxicity Caused by Brazilian PurpuricFever-Associated Strains of Haemophilus influenzae Biogroup Aegyptius

A Tissue Culture Model for Studying the Pathogenesis of Brazilian Purpuric Fever

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019

In vitro activity of ceftazidime-avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020

Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017–2020

Erratum for Estabrook et al., "Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019"

Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019

In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020

Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019

Design of a Brushless Doubly-Fed Machine for Aviation Electric Propulsion

In vitro Activity of Ceftaroline Against Isolates of Gram-Positive Bacteria from Patients with Bloodstream Infections Collected as a Part of ATLAS Between 2017 and 2020

Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019

The global response to the threat of antimicrobial resistance and the important role of vaccines

Antimicrobial Activity of Ceftazidime–Avibactam and Comparators Against Fluoroquinolone-Resistant Klebsiella pneumoniae Collected Globally from Antimicrobial Testing Leadership and Surveillance: 2018–2019

Vaccines: A review of immune-based interventions to prevent and treat disease

Cancer risk in living kidney donors

Aktive Filter

Suchergebnisse filtern